Skip to main content
SpringerLink
Log in

Hyperbaric Oxygen Enhances the Efficiency of 5-Aminosalicylic Acid in Acetic Acid–Induced Colitis in Rats

  • Inflammatory Bowel Disease
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The aim of this study was to assess the efficienchyperbaric oxygen alone and in combination with 5-aminosalicylic acid in THE acetic acid–induced colitis model, a well-known experimental model of inflammatory bowel disease in rats. Rats were randomly divided into FIVE groups. In the noncolitis control group, rats were given isotonic saline, while in the other groups rats were treated by intracolonic administration of 4% acetic acid. In group 2, the untreated control group, no additional therapy was applied. In groups 3, 4, and 5 hyperbaric oxygen, 5-aminosalicylic acid. and 5-aminosalicylic acid + hyperbaric oxygen therapies were applied, respectively. Administration of acetic acid caused an inflammatory response in all animals. Histopathologic score was significantly higher in group 2 than in any other group. 5-Aminosalicylic acid and hyperbaric oxygen significantly decreased the histopathologic score (P < 0.05). Myeloperoxidase activity was also reduced significantly by 5-aminosalicylic acid (P < 0.05) but not by hyperbaric oxygen. The most prominent ameliorative effect, however, was seen in group 5 and the histopathologic score and myeloperoxidase activity were significantly lower than in groups 3 (P < 0.05) and 4 (P < 0.001). Hydroxyproline level also increased significantly in group 5, but not in groups 3 and 4 (P < 0.001). These findings indicate that hyperbaric oxygen therapy is effective in reducing the extent of colitis induced by acetic acid, although it is not as potent as 5-aminosalicylic acid. The combination of hyperbaric oxygen and 5-aminosalicylic acid, however, led to a much more prominent reduction in the severitcolitis. Hyperbaric oxygen may have a promising place in the treatment of inflammatory bowel disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hanauer S: Medical therapy of ulcerative colitis. Lancet 342:412–417, 1993

    Article  CAS  PubMed  Google Scholar 

  2. Buchman AL, Fife C, Torres C, Smith L, Aristizibal J: Hyperbaric oxygen therapy for severe ulcerative colitis. J Clin Gastroenterol 33(4):337–339, 2001

    CAS  PubMed  Google Scholar 

  3. Grisham MB: Oxidants and free radicals in inflammatory bowel disease. Lancet 24;344(8926):859–861, 1994

    Google Scholar 

  4. Lih-Brody L, Powell SR, Collier KP, Reddy GM, Cerchia R, Kahn E, Weissman GS, Katz S, Floyd RA, McKinley MJ, Fisher S, Mullin GE: Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 41:2078–2086, 1996

    Article  CAS  PubMed  Google Scholar 

  5. Nassif A, Longo WE, Mazuski JE, Vernava AM, Kaminski DL. Role of cytokines and platelet-activating factor in inflammatory bowel disease. Implications for therapy: Dis Colon Rectum 39:217–223, 1996

    Article  CAS  PubMed  Google Scholar 

  6. Pavlick KP, Laroux FS, Fuseler J, Wolf RE, Gray L, Hoffman J, Grisham MB: Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease. Free Radic Biol Med 33(3):311–322, 2002

    Article  CAS  PubMed  Google Scholar 

  7. Rachmilewitz D, Karmeli F, Okon E, Rubenstein I, Better OS: Hyperbaric oxygen: a novel modality to ameliorate experimental colitis. Gut 43:512–518, 1998

    CAS  PubMed  Google Scholar 

  8. Shirley PJ, Ross JAS: Hyperbaric medicine part I: theory and practice. Curr Anesth Crit Care 12:114–120, 2001

    Google Scholar 

  9. LaVan FB, Hunt TK: Oxygen and wound healing. Clin Plast Surg 17:463–472, 1990

    CAS  PubMed  Google Scholar 

  10. Buras J: Basic mechanisms of hyperbaric oxygen in the treatment of ischemia-reperfusion injury. Int Anesthesiol Clin 38(1):91–109, 2000

    CAS  PubMed  Google Scholar 

  11. Buras JA, Stahl GL, Svoboda KK, Reenstra WR: Hyperbaric oxygen downregulates ICAM-1 expression induced by hypoxia and hypoglycemia: the role of NOS. Am J Physiol Cell Physiol 278(2):C292–C302, 2000

    CAS  PubMed  Google Scholar 

  12. Sharon P, Stenson WP: Metabolism of arachidonic acid in acetic colitis in rats: similarity to human inflammatory bowel disease. Gastroenterology 88:55–63, 1995

    Google Scholar 

  13. Krawisz JE, Sharon P, Stenson WF: Quantitative assay for intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87:1344–1350, 1984

    CAS  PubMed  Google Scholar 

  14. Jamall IS, Finelli VN, Que Hee SS: A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues. Anal Biochem 112:70–75, 1981

    Article  CAS  PubMed  Google Scholar 

  15. MacPherson BR, Pfeiffer C: Experimental production of diffuse colitis in rats. Digestion 17:135–150, 1978

    CAS  PubMed  Google Scholar 

  16. Yamada T, Zimmerman BJ, Specian R, Grisham MB: Role of neutrophils in acetic acid induced colitis in rats. Inflammation 15:399–411, 1991

    Article  CAS  PubMed  Google Scholar 

  17. Strober W: Animal models of inflammatory bowel disease–an overview. Dig Dis Sci 12:3S–10S, 1985

    Google Scholar 

  18. Dong WG, Liu SP, Yu BP, Wu DF, Luo HS, Yu JP: Ameliorative effects of sodium ferulate on experimental colitis and their mechanisms in rats. World J Gastroenterol. 9(11):2533–2538, 2003

    CAS  PubMed  Google Scholar 

  19. Elson CO, Sartor RB, Tennyson GS, Riddell RH: Experimental models of inflammatory bowel disease. Gastroenterology 109(4):1344–1367, 1995

    Article  CAS  PubMed  Google Scholar 

  20. Hawkey CJ, Rampton DS: Prostaglandins and the gastrointestinal mucosa: Are they important in its function, disease, or treatment? Gastroenterology 89:1162–1188, 1985

    CAS  PubMed  Google Scholar 

  21. Sharon P, Stenson WF: Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology 86:453–460, 1984

    CAS  PubMed  Google Scholar 

  22. Harris DW, Smith PR, Swan CH: Determination of prostaglandin synthetase activity in rectal biopsy material and its significance in colonic disease. Gut 19:875–877, 1978

    CAS  PubMed  Google Scholar 

  23. Dong WG, Liu SP, Yu BP, Wu DF, Luo HS, Yu JP: Ameliorative effects of sodium ferulate on experimental colitis and their mechanisms in rats. World J Gastroenterol 9(11):2533–2538, 2003

    CAS  PubMed  Google Scholar 

  24. Wahl C, Liptay S, Adler G, Schmid MR: Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J Clin Invest 101:1163–1174, 1998

    CAS  PubMed  Google Scholar 

  25. Kane SV, Bjorkman DJ: The efficacy of oral 5–ASAs in the treatment of active ulcerative colitis: a systematic review. Rev Gastroenterol Disord 3:210–218, 2003

    PubMed  Google Scholar 

  26. Baker DE, Kane S: The short and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis. Rev Gastroenterol Disord 4(2):86–91, 2004

    PubMed  Google Scholar 

  27. Carlin G, Djursater R, Smedegard G: Inhibitory effects of sulfasalazine and related compounds on superoxide production by human polymorphonuclear leukocytes. Pharmacol Toxicol 65:121–127, 1989

    CAS  PubMed  Google Scholar 

  28. Sheldon P, Webb C, Grindulis KA: Effect of sulphasalazine and its metabolites on mitogen induced transformation of lymphocytes–-Clues to its clinical action? Br J Rheumatol 27:344–349, 1988

    CAS  PubMed  Google Scholar 

  29. Fujiwara M, Mitsui K, Yamamoto I: Inhibition of proliferative responses and interleukin 2 production by salazosulfapyridine and its metabolites. Jpn J Pharmacol 54:121–132, 1990

    CAS  PubMed  Google Scholar 

  30. Gaginella TS, Walsh RE: Sulfasalazine: multiplicity of action Dig Dis Sci 37:801–812, 1992

    Article  CAS  PubMed  Google Scholar 

  31. Harris ML, Schiller HJ, Reilly PM, Donowitz M, Grisham MB, Bulkley GB: Free radicals and other reactive oxygen metabolites in inflammatory bowel disease: cause, consequence or epiphenomenon? Pharmacol Ther 53(3):375–408, 1992

    Article  CAS  PubMed  Google Scholar 

  32. Aruom OI, Wasil M, Halliwell B, Hoey BM, Butler J: The scavenging of oxidants by sulphasalazine and its metabolites. A possible contribution to their anti-inflammatory effects? Biochem Pharmacol 36:3739–3742, 1987

    Google Scholar 

  33. Gionchetti P, Guarnieri C, Campieri M, Bellusgi A, Brignola C, Tannone P, Miglioli M, Barbara C: Scavenger effect of sulfasalazine, 5-aminosalicylic acid, and osalazine on superoxide radical generation. Dig Dis Sci 36:174–178, 1991

    Article  CAS  PubMed  Google Scholar 

  34. Simmonds NJ, Millar AD, Blake DR, Rampton DS: Antioxidant effects of aminosalicylates and potential new drugs for inflammatory bowel disease: assessment in cell-free systems and inflamed human colorectal biopsies. Aliment Pharmacol Ther 13(3):363–372, 1999

    Article  CAS  PubMed  Google Scholar 

  35. Siebenlist U, Franzoso G, Brown K: Structure, regulation and function of NF-kB. Ann Rev Cell Biol 10:405–455, 1994

    CAS  PubMed  Google Scholar 

  36. Weber CK, Liptay S, Wirth T, Adler G, Schmid RM: Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of Ikappa B kinases alpha and beta. Gastroenterology 119(5):1209–1218, 2000

    Article  CAS  PubMed  Google Scholar 

  37. Isik AT, Mas MR, Comert B, Yasar M, Korkmaz A, Akay C, Deveci S, Tasci I, Mas N, Ates Y, Kocar IH: The effect of combination therapy of hyperbaric oxygen, meropenem, and selective nitric oxide synthase inhibitor in experimental acute pancreatitis. Pancreas 28(1):53–57, 2004

    CAS  PubMed  Google Scholar 

  38. Korkmaz A, Oter S, Deveci S, Ozgurtas T, Topal T, Sadir S, Bilgic H: Involvement of nitric oxide and hyperbaric oxygen in the pathogenesis of cyclophosphamide induced hemorrhagic cystitis in rats. J Urol 170(6, Pt 1):2498–2502, 2003

    Article  CAS  PubMed  Google Scholar 

  39. Oztas E, Kilic A, Ozyurt M, Korkmaz A, Basustaoglu A: Effect of hyperbaric oxygen and penicillin in a murine model of streptococcal myositis. Undersea Hyperb Med. 28(4):181–186, 2001

    CAS  PubMed  Google Scholar 

  40. Quirinia A, Viidik A: The effect of hyperbaric oxygen on different phases of healing of ischaemic flap wounds and incisional wounds in skin. Br J Plast Surg 48(8):583–589, 1995

    Article  CAS  PubMed  Google Scholar 

  41. Brady CE, Cooley BJ, Davis JC: Healing of severe perineal and cutaneous Crohn’s disease with hyperbaric oxygen. Gastroenterology 97:756–760, 1989

    PubMed  Google Scholar 

  42. Colombel JF, Mathieu D, Bouault JM, Lesage X, Zavadil P, Quandelle P, Cortot A: Hyperbaric oxygenation in severe perineal Crohn’s disease. Dis Colon Rectum 38:609–614, 1995

    Article  CAS  PubMed  Google Scholar 

  43. Lavy A, Weisz G, Adir Y, Ramon Y, Eidelman S: Hyperbaric oxygen for perianal Crohn’s disease. J Clin Gastroenterol 19:202–205, 1994

    CAS  PubMed  Google Scholar 

  44. Nelson EW JR, Bright DE, Villar LF: Closure of refractory perineal Crohn’s lesion: integration of hyperbaric oxygen into case management. Dig Dis Sci 35:1561–1565, 1990

    Article  PubMed  Google Scholar 

  45. Gulec B, Yasar M, Yildiz S, Oter S, Akay C, Deveci S, Sen D: Effect of hyperbaric oxygen on experimental acute distal colitis. Physiol Res 53:493–500, 2004

    CAS  PubMed  Google Scholar 

  46. Weisz G, Lavy A, Adir Y, Melamed Y, Rubin D, Eidelman S, Pollack S: Modification of in vivo and in vitro TNF-alpha, IL-1, and IL-6 secretion by circulating monocytes during hyperbaric oxygen treatment in patients with perianal Crohn’s disease. J Clin Immunol 17(2):154–159, 1997

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General Surgery, Gulhane Military Medical Academy, 06018, Etlik, Ankara, Turkey

    Semih Gorgulu MD, Gokhan Yagci MD, Nihat Kaymakcioglu MD, Murat Özkara & Turgut Tufan MD

  2. Department of Pathology, Gulhane Military Medical Academy, 06018, Etlik, Ankara, Turkey

    Bulent Kurt MD & Ayhan Ozcan MD

  3. Department of Biochemistry, Gulhane Military Medical Academy, 06018, Etlik, Ankara, Turkey

    Omer Kaya MD

  4. Department of Physiology, Gulhane Military Medical Academy, 06018, Etlik, Ankara, Turkey

    Serdar Sadir MD

  5. Department of General Surgery, Gulhane Military Medical Academy, 06018, Etlik, Ankara, Turkey

    Semih Gorgulu MD

Authors
  1. Semih Gorgulu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gokhan Yagci MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nihat Kaymakcioglu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Murat Özkara
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bulent Kurt MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ayhan Ozcan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Omer Kaya MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Serdar Sadir MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Turgut Tufan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Semih Gorgulu MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gorgulu, S., Yagci, G., Kaymakcioglu, N. et al. Hyperbaric Oxygen Enhances the Efficiency of 5-Aminosalicylic Acid in Acetic Acid–Induced Colitis in Rats. Dig Dis Sci 51, 480–487 (2006). https://doi.org/10.1007/s10620-006-3159-2

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-006-3159-2

Key Words

Search

Navigation